EADO 2020 | Access to novel therapies in melanoma

Bettina Ryll, MD, PhD, Melanoma Patient Network Europe, Uppsala, Sweden, outlines the importance of access to novel therapies and new treatment approaches for patients with melanoma, ensuring that scientific advances are helping the patients they are designed for. Dr Ryll also highlights language barriers as a challenge in accessing new therapies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).